Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.46 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.44 |
| ▸ | CPB2 | Q96IY4 | 8/20 | 0.42 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.39 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.36 |
| ▸ | CPB1 | P15086 | 2/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | LTA4H | P09960 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9716838 | 1.00 | GSR (0.46) | GSRRNPEPCPB2GABRR1FOLH1 | |
| Calcium SCHEMBL32679722 | 0.98 | GSR (0.44) | GSRRNPEPCPB2GABRR1FOLH1 | |
| SCHEMBL32679721 | 0.98 | GSR (0.44) | GSRRNPEPCPB2GABRR1FOLH1 | |
| SCHEMBL9716745 | 0.95 | GABRR1 (0.41) | GSRRNPEPCPB2GABRR1FOLH1 | |
| SCHEMBL9716741 | 0.95 | GABRR1 (0.41) | GSRRNPEPCPB2GABRR1FOLH1 | |
| SCHEMBL7265699 | 0.88 | GSR (0.44) | GSRRNPEPCPB2GABRR1FOLH1 | |
| SCHEMBL7265705 | 0.88 | GSR (0.44) | GSRRNPEPCPB2GABRR1FOLH1 | |
| SCHEMBL31341035 | 0.83 | GSR (0.35) | GSRRNPEPCPB2 | |
| SCHEMBL31340926 | 0.83 | GSR (0.35) | GSRRNPEPCPB2 | |
| SCHEMBL31283191 | 0.83 | GSR (0.35) | GSRRNPEPCPB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4746865-A1 | NOVEL AMINO ACID BASED SALTS, COMPOSITIONS AND METHODS FOR TREATING SKIN AND REJUVENATING SKIN AND EXTENDING LONGEVITY | Sytheon Ltd. (US) | 2026-05-27 | — | — | EP | disclosed |
| EP-4746847-A2 | COMPOSITION & METHODS FOR REGULATING MELANOGENESIS | Sytheon Ltd. (US) | 2026-05-27 | — | — | EP | disclosed |
| CN-121586570-A | Compositions and methods for modulating melanogenesis | 赛泽恩有限公司 | 2026-02-27 | — | — | CN | disclosed |
| US-20260041620-A1 | NOVEL AMINO ACID BASED SALTS, COMPOSITIONS AND METHODS FOR TREATING SKIN AND IMPROVING SKIN REJUVENATION AND LONGEVITY | SYTHEON LTD (US) | 2026-02-12 | — | — | US | disclosed |
| US-20250099355-A1 | AMINO ACID BASED SALTS, COMPOSITIONS AND METHODS FOR TREATING SKIN AND IMPROVING SKIN REJUVENATION AND LONGEVITY | SYTHEON LTD (US) | 2025-03-27 | — | — | US | disclosed |
| WO-2025019570-A1 | NOVEL AMINO ACID BASED SALTS, COMPOSITIONS AND METHODS FOR TREATING SKIN AND REJUVENATING SKIN AND EXTENDING LONGEVITY | SYTHEON LTD. (US) | 2025-01-23 | — | — | WO | disclosed |
| WO-2025019573-A2 | COMPOSITION & METHODS FOR REGULATING MELANOGENESIS | SYTHEON LTD. (US) | 2025-01-23 | — | — | WO | disclosed |
| US-12171852-B1 | Composition and methods for regulating melanogenesis | SYTHEON LTD (US) | 2024-12-24 | — | — | US | disclosed |
| EP-0178911-B1 | COMPOSITION CONTAINING A PENEM OR CARBAPENEM ANTIBIOTIC | SANKYO COMPANY LIMITED (JP) | 1992-01-22 | — | — | EP | disclosed |
| EP-0178911-A2 | Composition containing a penem or carbapenem antibiotic | SANKYO COMPANY LIMITED (JP) | 1986-04-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250099355-A1 | AMINO ACID BASED SALTS, COMPOSITIONS AND METHODS FOR TREATING SKIN AND IMPROVING SKIN REJUVENATION AND LONGEVITY | AADAT, BCAT2, BCAT1 | GSR 1591/4885RNPEP 175/4885CPB2 2996/4885 |
| US-20260041620-A1 | NOVEL AMINO ACID BASED SALTS, COMPOSITIONS AND METHODS FOR TREATING SKIN AND IMPROVING SKIN REJUVENATION AND LONGEVITY | TYR, ARG2, BCAT2 | GSR 340/4885RNPEP 1714/4885CPB2 3152/4885 |
| US-12171852-B1 | Composition and methods for regulating melanogenesis | TYR, MITF, MC1R | GSR 2322/4885RNPEP 1244/4885CPB2 3980/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.